Trulieve Cannabis Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Trulieve Cannabis wird ein Gewinn- und Umsatzwachstum von 59.8% bzw. 6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 73% pro Jahr wachsen soll.

Wichtige Informationen

59.8%

Wachstumsrate der Gewinne

73.0%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	53.4%
Wachstumsrate der Einnahmen	6.0%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?

Sep 04

Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 15

Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year

Jun 06

Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?

May 01

Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%

Mar 31

Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?

Feb 15

There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump

Jan 16

Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)

Mar 06

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Jan 26

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Aug 07

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Jul 03

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Mar 21

Is Trulieve Cannabis (CSE:TRUL) Using Too Much Debt?

Aug 16

Gewinn- und Umsatzwachstumsprognosen

CNSX:TRUL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,327	N/A	N/A	221	2
12/31/2025	1,234	-56	157	211	11
12/31/2024	1,178	-147	129	246	11
9/30/2024	1,172	-126	254	372	N/A
6/30/2024	1,163	-90	361	437	N/A
3/31/2024	1,142	-419	287	343	N/A
12/31/2023	1,129	-431	152	207	N/A
9/30/2023	1,141	-458	60	139	N/A
6/30/2023	1,161	-508	-91	23	N/A
3/31/2023	1,193	-185	-174	-20	N/A
12/31/2022	1,218	-179	-172	21	N/A
9/30/2022	1,225	-185	-309	-105	N/A
6/30/2022	1,153	-95	-300	-58	N/A
3/31/2022	1,055	-37	-263	-2	N/A
12/31/2021	932	31	-301	9	N/A
9/30/2021	801	93	-162	102	N/A
6/30/2021	714	91	-156	71	N/A
3/31/2021	619	69	-37	135	N/A
12/31/2020	522	63	-47	100	N/A
9/30/2020	433	-19	-35	76	N/A
6/30/2020	367	23	-11	77	N/A
3/31/2020	304	62	-57	33	N/A
12/31/2019	253	53	-56	19	N/A
9/30/2019	209	128	-49	24	N/A
6/30/2019	167	85	-26	36	N/A
3/31/2019	132	36	-21	34	N/A
12/31/2018	103	11	-20	24	N/A
9/30/2018	80	33	-9	19	N/A
6/30/2018	55	16	N/A	10	N/A
3/31/2018	33	9	N/A	2	N/A
12/31/2017	20	4	N/A	0	N/A
12/31/2016	0	-4	N/A	-4	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: TRUL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: TRUL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: TRUL wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: TRULDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (7.1% pro Jahr).

Hohe Wachstumseinnahmen: TRULDie Einnahmen des Unternehmens (6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von TRUL in 3 Jahren voraussichtlich hoch sein wird

Trulieve Cannabis Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Trulieve Cannabis Corp. Provides Revenue Guidance for the Third Quarter of 2023

Consensus EPS estimates fall by 33%

Trulieve Cannabis Corp. Provides Earnings Guidance for the Year 2022

Trulieve Cannabis Corp. Revises Revenue Guidance for the Fiscal Year 2022

Consensus forecasts updated

Trulieve Cannabis Corp. Reiterates Earnings Guidance for 2022 and Provides Earnings Guidance for the Second Half of 2022

Recent updates

Trulieve Cannabis Corp. to Report Q3, 2024 Results on Nov 05, 2024

Trulieve Opens Relocated Dispensary in Tucson, Arizona

Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 47%?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Trulieve Cannabis Corp. Launches #YesOn3 Product Line to Support Adult Use Campaign in Florida

Trulieve Cannabis Corp. to Report Q2, 2024 Results on Aug 06, 2024

Insufficient new directors

Trulieve Cannabis Corp.'s (CSE:TRUL) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Trulieve Cannabis Corp.'s (CSE:TRUL) CEO Will Probably Struggle To See A Pay Rise This Year

Trulieve Cannabis Corp. (CNSX:TRUL) agreed to acquire Harvest of Ohio LLC from Ariane Kirkpatrick.

First quarter 2024 earnings released: US$0.12 loss per share (vs US$0.17 loss in 1Q 2023)

Are Investors Undervaluing Trulieve Cannabis Corp. (CSE:TRUL) By 38%?

Trulieve Cannabis Corp. to Report Q1, 2024 Results on May 09, 2024

Revenues Not Telling The Story For Trulieve Cannabis Corp. (CSE:TRUL) After Shares Rise 26%

Trulieve Cannabis Corp., Annual General Meeting, Jun 12, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Trulieve Cannabis (CSE:TRUL) A Risky Investment?

Trulieve Cannabis Corp. to Report Q4, 2023 Results on Feb 29, 2024

There's Reason For Concern Over Trulieve Cannabis Corp.'s (CSE:TRUL) Massive 29% Price Jump

Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer, Effective January 29, 2024

Trulieve Cannabis Corp. Announces Chief Financial Officer Changes

Trulieve Cannabis Corp. Announces Chief Financial Officer Changes

Trulieve Cannabis Corp. to Report Q3, 2023 Results on Nov 09, 2023

Trulieve Cannabis Corp. Announces Relocation of Medical Cannabis Dispensary in Melbourne, Florida

Trulieve Cannabis Corp. Announces Stepping Down of Steve White as President

Trulieve Cannabis Corp. Provides Revenue Guidance for the Third Quarter of 2023

Trulieve Cannabis Corp. Announces the Relocation of Medical Dispensary in Kissimmee, Florida

Trulieve Cannabis Corp. Announces CFO Changes

Trulieve Cannabis Corp. to Report Q2, 2023 Results on Aug 09, 2023

Trulieve Cannabis Corp. Announces Appointment of Tim Mullany as Chief Financial Officer

Trulieve Continues Optimization Efforts with Closure of California Retail Location and Plan to Wind Down Massachusetts Operations

Consensus EPS estimates fall by 33%

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Joy Malivuk Appoints as the Vice President, Chief Accounting Officer of Trulieve Cannabis Corp

Full year 2022 earnings: EPS misses analyst expectations

Now 22% undervalued after recent price drop

Calculating The Intrinsic Value Of Trulieve Cannabis Corp. (CSE:TRUL)

Trulieve Cannabis Corp. Announces to Begin Adult-Use Cannabis Sales At Relocated Bristol, CT Dispensary

Trulieve Cannabis Corp. to Report Q4, 2022 Results on Mar 01, 2023

Trulieve Cannabis Corp. Introduces New Products to West Virginia in February

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Extensively

Trulieve Cannabis Corp. Launches Highsman Cannabis Products from NFL Legend Ricky Williams in Arizona

Trulieve Cannabis Corp. Announces Resignation of Rebecca L. Young as Chief Accounting Officer

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Maryland Through Exclusive Partnership with Wiz Khalifa

Trulieve Launches Khalifa Kush Cannabis in Pennsylvania Through Exclusive Partnership with Wiz Khalifa

Trulieve Cannabis Corp. Provides Earnings Guidance for the Year 2022

Trulieve Cannabis Corp. to Report Q3, 2022 Results on Nov 09, 2022

Trulieve Cannabis Corp. Launches Khalifa Kush Cannabis in Florida Through Exclusive Partnership with Wiz Khalifa

Trulieve Announces Opening of Relocated Edgewater Dispensary in Florida

Second quarter 2022 earnings: EPS misses analyst expectations

Trulieve Cannabis Corp. Revises Revenue Guidance for the Fiscal Year 2022

Does Trulieve Cannabis (CSE:TRUL) Have A Healthy Balance Sheet?

Trulieve Cannabis Corp. to Report Q2, 2022 Results on Aug 10, 2022

Consensus forecasts updated

Are Trulieve Cannabis Corp. (CSE:TRUL) Investors Paying Above The Intrinsic Value?

Founder recently bought CA$260k worth of stock

Trulieve Cannabis Corp. Opens Two Medical Dispensary in West Virginia

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Trulieve Cannabis Corp. Reiterates Earnings Guidance for 2022 and Provides Earnings Guidance for the Second Half of 2022

High number of new directors

Consensus forecasts updated

Consensus forecasts updated

Consensus EPS estimates fall by 64%

Full year 2021 earnings: Revenues in line with analyst expectations

Trulieve Cannabis Corp. Announces Impairment Charges for the Quarter Ended December 31, 2021

These 4 Measures Indicate That Trulieve Cannabis (CSE:TRUL) Is Using Debt Reasonably Well

Trulieve Cannabis Corp. to Report Q4, 2021 Results on Mar 30, 2022

Investor sentiment deteriorated over the past week